Literature DB >> 24158167

Prevalence, risk factors, and mortality for ventilator-associated pneumonia in middle-aged, old, and very old critically ill patients*.

Stijn Blot1, Despoina Koulenti, George Dimopoulos, Claude Martin, Apostolos Komnos, Wolfgang A Krueger, Giuseppe Spina, Apostolos Armaganidis, Jordi Rello.   

Abstract

OBJECTIVE: We investigated the epidemiology of ventilator-associated pneumonia in elderly ICU patients. More precisely, we assessed prevalence, risk factors, signs and symptoms, causative bacterial pathogens, and associated outcomes.
DESIGN: Secondary analysis of a multicenter prospective cohort (EU-VAP project).
SETTING: Twenty-seven European ICUs. PATIENTS: Patients who were mechanically ventilated for greater than or equal to 48 hours. We compared middle-aged (45-64 yr; n = 670), old (65-74 yr; n = 549), and very old patients (≥ 75 yr; n= 516).
MEASUREMENTS AND MAIN RESULTS: Ventilator-associated pneumonia occurred in 103 middle-aged (14.6%), 104 old (17.0%), and 73 very old patients (12.8%). The prevalence (n ventilator-associated pneumonia/1,000 ventilation days) was 13.7 in middle-aged patients, 16.6 in old patients, and 13.0 in very old patients. Logistic regression analysis could not demonstrate older age as a risk factor for ventilator-associated pneumonia. Ventilator-associated pneumonia in elderly patients was more frequently caused by Enterobacteriaceae (24% in middle-aged, 32% in old, and 43% in very old patients; p = 0.042). Regarding clinical signs and symptoms at ventilator-associated pneumonia onset, new temperature rise was less frequent among very old patients (59% vs 76% and 74% for middle-aged and old patients, respectively; p = 0.035). Mortality among patients with ventilator-associated pneumonia was higher among elderly patients: 35% in middle-aged patients versus 51% in old and very old patients (p = 0.036). Logistic regression analysis confirmed the importance of older age in the risk of death (adjusted odds ratio for old age, 2.1; 95% CI, 1.2-3.9 and adjusted odds ratio for very old age, 2.3; 95% CI, 1.2-4.4). Other risk factors for mortality in ventilator-associated pneumonia were diabetes mellitus, septic shock, and a high-risk pathogen as causative agent.
CONCLUSIONS: In this multicenter cohort study, ventilator-associated pneumonia did not occur more frequently among elderly, but the associated mortality in these patients was higher. New temperature rise was less common in elderly patients with ventilator-associated pneumonia, whereas more episodes among elderly patients were caused by Enterobacteriaceae.

Entities:  

Mesh:

Year:  2014        PMID: 24158167     DOI: 10.1097/01.ccm.0000435665.07446.50

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  41 in total

1.  Effect of heart rate on hospital mortality in critically ill patients may be modified by age: a retrospective observational study from large database.

Authors:  Dawei Zhou; Zhimin Li; Guangzhi Shi; Jianxin Zhou
Journal:  Aging Clin Exp Res       Date:  2020-07-07       Impact factor: 3.636

2.  Healthcare-associated pneumonia among U.S. combat casualties, 2009 to 2010.

Authors:  Heather C Yun; Amy C Weintrob; Nicholas G Conger; Ping Li; Dan Lu; David R Tribble; Clinton K Murray
Journal:  Mil Med       Date:  2015-01       Impact factor: 1.437

3.  Staphylococcus aureus carriage at admission predicts early-onset pneumonia after burn trauma.

Authors:  A Fournier; P Voirol; M Krähenbühl; C-L Bonnemain; C Fournier; E Dupuis-Lozeron; O Pantet; J-L Pagani; J-P Revelly; F Sadeghipour; P Eggimann; Y-A Que
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-11-04       Impact factor: 3.267

4.  Identification of Factors Affecting Mortality in Late-Onset Ventilator-Associated Pneumonia.

Authors:  Aziz Ahmad Hamidi; Serhat Kescioglu
Journal:  Eurasian J Med       Date:  2020-10

5.  Geriatric Burn Injuries Presenting to the Emergency Department of a Major Burn Center: Clinical Characteristics and Outcomes.

Authors:  David K Lachs; Michael E Stern; Alyssa Elman; Kriti Gogia; Sunday Clark; Mary R Mulcare; Andrew Greenway; Daniel Golden; Rahul Sharma; Palmer Q Bessey; Tony Rosen
Journal:  J Emerg Med       Date:  2022-05-28       Impact factor: 1.473

6.  Frequency, Etiology, Mortality, Cost, and Prevention of Respiratory Tract Infections-Prospective, One Center Study.

Authors:  Wieslawa Duszynska; Marta Idziak; Klaudia Smardz; Anna Burkot; Malgorzata Grotowska; Stanislaw Rojek
Journal:  J Clin Med       Date:  2022-06-29       Impact factor: 4.964

7.  Ventilator-Associated Pneumonia-Quantum Uncertainty in the ICU?

Authors:  Andrew Conway Morris
Journal:  Crit Care Med       Date:  2018-06       Impact factor: 7.598

Review 8.  Nosocomial pneumonia in 27 ICUs in Europe: perspectives from the EU-VAP/CAP study.

Authors:  D Koulenti; E Tsigou; J Rello
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-06-10       Impact factor: 3.267

9.  Antifungal therapy in patients with pulmonary Candida spp. colonization may have no beneficial effects.

Authors:  Simone Lindau; Manuel Nadermann; Hanns Ackermann; Tobias Michael Bingold; Christoph Stephan; Volkhard A J Kempf; Pia Herzberger; Andres Beiras-Fernandez; Kai Zacharowski; Patrick Meybohm
Journal:  J Intensive Care       Date:  2015-07-03

Review 10.  Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults.

Authors:  Richard Pugh; Chris Grant; Richard P D Cooke; Ged Dempsey
Journal:  Cochrane Database Syst Rev       Date:  2015-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.